Tech Company Financing Transactions

METiS Therapeutics Funding Round

METiS Therapeutics secured a $86 million Series A funding round on 12/8/2021. Investors included China Life Insurance, PICC Capital Investment Management and 5Y Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

245 Main St.
Cambridge, MA 02142
USA

Phone

Undisclosed

Website

www.metistx.com

Email Address

[email protected]

Overview

METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Chris Lai

        

Chief Operating Officer

Wenshou Wang

        

Browse more venture capital transactions:

Prev: 12/8/2021: Universe venture capital transaction
Next: 12/8/2021: Everphone venture capital transaction

Share this article

Where The Data Comes From

We record all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary